Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Screening Efficacy of Available Hiv Protease Inhibitors on Covid-19 Protease Publisher



Mirzaei M1 ; Harismah K2 ; Dai M3 ; Salarrezaei E4 ; Roshandel Z4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Biosensor Research Center, School of Advanced Technologies in Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Chemical Engineering, Faculty of Engineering, Universitas Muhammadiyah Surakarta, Surakarta, Indonesia
  3. 3. Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Universitas Muhammadiyah Surakarta, Surakarta, Indonesia
  4. 4. Department of Biomaterials, Nanotechnology and Tissue Engineering, School of Advanced Technologies in Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Military Medicine Published:2020


Abstract

Background and Aim: Advent of COVID-19 attracted the attentions of researchers to develop drugs for its treatment. Besides efforts on developing new drugs, screening available drugs to see their efficacy on COVID-19 could be an urgent action of initiating its pharmacotherapy. In this study, efficacy of HIV protease inhibitors on COVID-19 protease has been examined. Methods: Molecular docking based screening by AutoDock software has been done to examine the efficacy of ligand-receptor interactions. Results: Obtained results of binding energy, inhibitory constant and interactions quality have approved the idea of efficacy of HIV protease inhibitors on COVID-19 protease. Conclusion: Quantitative results indicated different levels of efficacy of investigated ligands for inhibitory activity of COVID-19 and qualitative results indicated various localizations of ligands in the proposed active site of protease. The concluding remarks of this study are to introduce Nelfinavir as the best ligand in quantitative respect and each of Saquinavir, Amprenavir and Fosamprenavir as the best ligands inqualitative respect for possible inhibitory effects on COVID-19 protease. © 2020 Baqiyatallah University of Medical Sciences. All rights reserved.
Related Docs
View other Related Docs
1. Screening of Potential Inhibitors of Covid-19 With Repurposing Approach Via Molecular Docking, Network Modeling Analysis in Health Informatics and Bioinformatics (2022)
2. Design and Synthesis of Novel Phe-Phe Hydroxyethylene Derivatives As Potential Coronavirus Main Protease Inhibitors, Journal of Biomolecular Structure and Dynamics (2022)
3. An In-Silico Screening Strategy to the Prediction of New Inhibitors of Covid-19 Mpro Protein, Iranian Journal of Pharmaceutical Research (2021)
4. Effect of Biomolecular Conformation on Docking Simulation: A Case Study on a Potent Hiv-1 Protease Inhibitor, Iranian Journal of Pharmaceutical Research (2015)
5. Drug Repositioning Approach to Target Viral and Host Cells in Terms of Covid-19 Treatment: A Review of in Vivo Experiments and Clinical Studies, Journal of Experimental and Clinical Medicine (Turkey) (2022)
6. Identification of Novel 3-Hydroxy-Pyran-4-One Derivatives As Potent Hiv-1 Integrase Inhibitors Using in Silico Structure-Based Combinatorial Library Design Approach, Frontiers in Chemistry (2019)
7. Investigation of Potential Antiviral Natural Products With an Effect on Hpv18 E6 Protein by Molecular Docking Method, Functional Foods in Health and Disease (2021)
8. Quantum Processing of Cytidine Derivatives and Evaluating Their in Silico Interactions With the Covid-19 Main Protease, Main Group Chemistry (2022)
Experts (# of related papers)
View all Related Experts
Afshin Fassihi (3)
Lotfollah Saghaie Dehkordi (2)
Other Related Docs
9. Inhibitory Effects of Curcumin on Aldose Reductase and Cyclooxygenase-2 Enzymes, Journal of Biomolecular Structure and Dynamics (2021)
10. Investigation of the Mutated Antimicrobial Peptides to Inhibit Ace2, Tmprss2 and Grp78 Receptors of Sars-Cov-2 and Angiotensin Ii Type 1 Receptor (At1r) As Well As Controlling Covid-19 Disease, Journal of Biomolecular Structure and Dynamics (2025)
11. Towards Screening and Repurposing of Approved Drugs for the Treatment of Covid-19 Using Molecular Docking, Physical Chemistry Research (2023)
12. In Silico Interactions of Some of the Triazole Derivatives With the Main Protease of Coronavirus, Biointerface Research in Applied Chemistry (2023)
13. Drug Repurposing for Diabetes Mellitus: In Silico and in Vitro Investigation of Drugbank Database for Α-Glucosidase Inhibitors, International Journal of Biological Macromolecules (2024)
14. A Comprehensive Review of Therapeutic Options for Covid-19, Ethiopian Journal of Health Development (2022)
15. Therapeutic Targets of Natural Products for the Management of Cardiovascular Symptoms of Coronavirus Disease 2019, Phytotherapy Research (2021)
16. Gp41 Inhibitory Activity Prediction of Theaflavin Derivatives Using Ligand/Structure-Based Virtual Screening Approaches, Computational Biology and Chemistry (2019)
17. Virtual Screening for the Identification of Potential Candidate Molecules Against Envelope (E) and Membrane (M) Proteins of Sars-Cov-2, Journal of Computational Biophysics and Chemistry (2021)
18. Potential Inhibitors of Sars-Cov-2: Recent Advances, Journal of Drug Targeting (2021)
19. Novel Drug Design for Treatment of Covid-19: A Systematic Review of Preclinical Studies, Canadian Journal of Infectious Diseases and Medical Microbiology (2022)
20. Bioinformatic Screening of Compounds From Iranian Lamiaceae Family Members Against Sars-Cov-2 Spike Protein, Letters in Drug Design and Discovery (2023)
21. Synthesis, Molecular Docking and Molecular Dynamics Simulation of 2- Thioxothiazolidin-4-One Derivatives Against Gp41, Current HIV Research (2020)
22. Drug Repurposing Against Angiotensin-Converting Enzyme-Related Carboxypeptidase (Ace2) Through Computational Approach, Journal of Medical Signals and Sensors (2022)